摘要
分子靶向治疗作为肿瘤治疗的新手段,以其低毒、高效等特性正成为肿瘤研究的热点。分子靶向药物包括表皮生长因子受体通路抑制剂、抗血管生成剂、环氧化酶-2抑制剂、抗CD20单克隆抗体等。大量临床应用结果表明,分子靶向药物在肿瘤治疗中具有显著疗效。本文综述了近年来肿瘤分子靶向治疗领域的进展。
Molecular targeted therapy is a new approach for tumor treatment,with the advantages of lower toxicity and higher efficiency.This approach has become a critical focus of tumor research.It includes epidermal growth factor receptor inhibitors,anti-angiogenesis drugs,cyclooxygenase-2 inhibitors,anti-CD20 monoclonal antibodies,etc.A large number of clinical applications show that molecular targeted therapy has significant effects on tumor.This review summarized the progress of molecular targeted therapy in recent years.
出处
《武汉大学学报(医学版)》
CAS
北大核心
2011年第5期705-708,共4页
Medical Journal of Wuhan University
关键词
肿瘤
分子靶向治疗
表皮生长因子受体
抗血管生成
Tumor
Molecular Targeted Therapy
Epidermal Growth Factor Receptor
Anti-Angiogenesis